Terug
Dagbereik
€ 5,25
€ 5,54
52-Weeksbereik
€ 3,81
€ 10,08
Volume
1.873.971
50D / 200D Gem.
€ 6,75
/
€ 6,88
Vorige Slotkoers
€ 5,61
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1646,5 | 0,3 |
| P/B | 66,6 | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 0,2 | 3,8 |
| Rev Growth 5Y % | 55,8 | 10,0 |
| D/E | 2,8 | 0,2 |
Koersdoel Analisten
Hold
€ 13,50
+155.2%
Low: € 9,00
High: € 18,00
Forward K/W
46,8
Forward WPA
€ 0,12
WPA Groei (sch.)
+0,0%
Omzet Sch.
380 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,09
€ 1,06 – € 1,14
|
700 M | 1 |
| FY2029 |
€ 0,89
€ 0,87 – € 0,93
|
610 M | 1 |
| FY2028 |
€ 0,59
€ 0,38 – € 0,82
|
540 M | 5 |
Belangrijkste Punten
Revenue grew 55,75% annually over 5 years — strong growth
Debt/Equity of 2,76 — high leverage
Generating 27,93M in free cash flow
P/E of 1646,50 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,03%
Cash machine — converts 5041,52% of earnings into free cash flow
Groei
Revenue Growth (5Y)
55,75%
Revenue (1Y)43,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC36,29%
Net Margin0,19%
Op. Margin8,53%
Veiligheid
Debt / Equity
2,76
Current Ratio2,19
Interest Coverage0,86
Waardering
P/E Ratio
1646,50
P/B Ratio66,63
EV/EBITDA33,70
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 43,72% | Revenue Growth (3Y) | 33,43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 55,75% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 291,85M | Net Income (TTM) | 554.000,0 |
| ROE | N/A | ROA | 0,14% |
| Gross Margin | 81,70% | Operating Margin | 8,53% |
| Net Margin | 0,19% | Free Cash Flow (TTM) | 27,93M |
| ROIC | 36,29% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,76 | Current Ratio | 2,19 |
| Interest Coverage | 0,86 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 1646,50 | P/B Ratio | 66,63 |
| P/S Ratio | 3,13 | PEG Ratio | -22,52 |
| EV/EBITDA | 33,70 | Dividend Yield | 0,00% |
| Market Cap | 912,16M | Enterprise Value | 838,88M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 291,85M | 203,07M | 163,91M | 110,25M | 49,59M |
| Net Income | 554.000,0 | -54,84M | -62,26M | -94,66M | -122,73M |
| EPS (Diluted) | 0,00 | -0,37 | -0,45 | -0,70 | -1,55 |
| Gross Profit | 238,43M | 166,24M | 135,27M | 87,61M | 36,27M |
| Operating Income | 24,90M | -33,65M | -44,01M | -81,94M | -115,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 383,53M | 323,06M | 322,60M | 344,52M | 304,36M |
| Total Liabilities | 369,84M | 352,68M | 329,38M | 299,34M | 209,13M |
| Shareholders' Equity | 13,69M | -29,62M | -6,78M | 45,19M | 95,23M |
| Total Debt | 37,76M | 271,45M | 229,19M | 198,06M | 88,07M |
| Cash & Equivalents | 111,04M | 71,62M | 67,45M | 121,97M | 67,27M |
| Current Assets | 240,31M | 167,66M | 156,26M | 186,82M | 142,60M |
| Current Liabilities | 109,57M | 100,44M | 95,19M | 73,62M | 79,04M |